Cargando…

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection

Coronavirus disease 2019 (COVID-19) continuously progresses despite the application of a variety of vaccines. Therefore, it is still imperative to find effective ways for treating COVID-19. Recent studies indicate that NRP1, an important receptor of the natural peptide tuftsin (released from IgG), f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jiahao, Wang, Jing, Li, Yan, Wang, Ziyuan, Chu, Ming, Wang, Yuedan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984176/ https://www.ncbi.nlm.nih.gov/pubmed/35402510 http://dx.doi.org/10.3389/fmolb.2022.859162

Ejemplares similares

Modeling of the thermal properties of SARS-CoV-2 S-protein
por: Niu, Ziyuan, et al.
Publicado: (2022)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
por: Xie, Yixin, et al.
Publicado: (2020)

Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline
por: Lau, Edmond Y., et al.
Publicado: (2021)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M(pro)) as Potential COVID-19 Therapies
por: Piplani, Sakshi, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 3CL M(pro) by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19
por: Ullah, Anwar, et al.
Publicado: (2021)

Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues
por: Feng, Qiushi, et al.
Publicado: (2020)

Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2
por: Sobitan, Adebiyi, et al.
Publicado: (2021)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Phytochemicals of Euphorbia hirta L. and Their Inhibitory Potential Against SARS-CoV-2 Main Protease
por: Cayona, Ruel, et al.
Publicado: (2022)

Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
por: Mahmud, Shafi, et al.
Publicado: (2021)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
por: Zhao, Xiaohui, et al.
Publicado: (2021)

SARS-CoV-2 Virion Stabilization by Zn Binding
por: Morante, Silvia, et al.
Publicado: (2020)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
por: Yue, Jingwen, et al.
Publicado: (2021)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
por: Barberis, Elettra, et al.
Publicado: (2021)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Clinical and Gene Features of SARS-CoV-2-Positive Recurrence in Patients Recovered From COVID-19
por: Peng, Yuying, et al.
Publicado: (2022)

Editorial: Interaction of Biomolecules and Bioactive Compounds With the SARS-CoV-2 Proteins: Molecular Simulations for the Fight Against Covid-19
por: Falconi, Mattia, et al.
Publicado: (2022)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
por: Pirone, Luciano, et al.
Publicado: (2020)

Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
por: Miotto, Mattia, et al.
Publicado: (2021)

Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis
por: Vandelli, Andrea, et al.
Publicado: (2022)

Structural understanding of SARS-CoV-2 virus entry to host cells
por: Le, Kim, et al.
Publicado: (2023)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
por: Dolskiy, Alexander A., et al.
Publicado: (2020)

Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2
por: Biswas, Suvro, et al.
Publicado: (2022)

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
por: Gelbach, Adrianne L., et al.
Publicado: (2022)

Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 on metabolic unhealthy obese patients
por: Huang, Tengda, et al.
Publicado: (2023)

Translocation pause of remdesivir-containing primer/template RNA duplex within SARS-CoV-2’s RNA polymerase complexes
por: Shi, Yuanjun, et al.
Publicado: (2022)

Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations
por: Yang, Rui, et al.
Publicado: (2022)

Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches
por: Waqas, Muhammad, et al.
Publicado: (2020)

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
por: Mariano, Giuseppina, et al.
Publicado: (2020)

SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan
por: Khan, Adnan, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
por: Malik, Yashpal S., et al.
Publicado: (2021)

CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2
por: Shademan, Behrouz, et al.
Publicado: (2022)

In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2
por: Milanetti, Edoardo, et al.
Publicado: (2021)

SARS-CoV-2 infection as a potential risk factor for the development of cancer
por: Ogarek, Natalia, et al.
Publicado: (2023)

Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel
por: Cao, Yipeng, et al.
Publicado: (2020)

SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness
por: Shinu, Pottathil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vp7fivrubuu7b2qhj1g2fc4i5